Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M23,542Revenue $M4,785Net Margin (%)12.2Z-Score4.2
Enterprise Value $M26,336EPS $1.2Operating Margin %19.7F-Score8
P/E(ttm))41.9Cash Flow Per Share $0Pre-tax Margin (%)17.1Higher ROA y-yY
Price/Book17.510-y EBITDA Growth Rate %0Quick Ratio2.0Cash flow > EarningsY
Price/Sales4.95-y EBITDA Growth Rate %0Current Ratio3.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %13.4ROA % (ttm)8.9Higher Current Ratio y-yY
Dividend Yield %0.6Insider Buy (3m)0ROE % (ttm)49.0Less Shares Outstanding y-yN
Payout Ratio %25.0Shares Outstanding M501ROI % (ttm)8.4Gross Margin Increase y-yY

Gurus Latest Trades with ZTS

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZTSBill Ackman 2014-12-31 Add9.62%$35.07 - $44.93
($40.72)
$ 47.3116%Add 650.78%41,569,646
ZTSMario Gabelli 2014-12-31 Add0.09%$35.07 - $44.93
($40.66)
$ 47.3116%Add 187.59%626,893
ZTSRobert Olstein 2014-12-31 Reduce-0.18%$35.07 - $44.93
($40.66)
$ 47.3116%Reduce -20.79%141,000
ZTSVanguard Health Care Fund 2014-12-31 Reduce-0.15%$35.07 - $44.93
($40.66)
$ 47.3116%Reduce -15%9,178,657
ZTSJean-Marie Eveillard 2014-12-31 Reduce-0.12%$35.07 - $44.93
($40.66)
$ 47.3116%Reduce -62.26%820,467
ZTSJohn Keeley 2014-12-31 Reduce-0.01%$35.07 - $44.93
($40.66)
$ 47.3116%Reduce -21.81%62,164
ZTSBill Ackman 2014-09-30 Buy 1.5%$31.79 - $37.2
($34.27)
$ 47.3138%New holding, 5536862 sh.5,536,862
ZTSJoel Greenblatt 2014-09-30 Sold Out -0.01%$31.79 - $37.2
($34.27)
$ 47.3138%Sold Out0
ZTSJoel Greenblatt 2014-06-30 Reduce$28.4 - $32.89
($30.65)
$ 47.3154%Reduce -22.04%33,034
ZTSJean-Marie Eveillard 2014-06-30 Reduce-0.12%$28.4 - $32.89
($30.65)
$ 47.3154%Reduce -42.15%2,177,060
ZTSGeorge Soros 2014-03-31 Add0.49%$29.01 - $32.69
($30.64)
$ 47.3154%Add 68.52%4,205,043
ZTSVanguard Health Care Fund 2014-03-31 Add0.16%$29.01 - $32.69
($30.63)
$ 47.3154%Add 23.89%10,421,717
ZTSJoel Greenblatt 2014-03-31 Buy 0.02%$29.01 - $32.69
($30.64)
$ 47.3154%New holding, 42374 sh.42,374
ZTSLee Ainslie 2014-03-31 Sold Out -3.2%$29.01 - $32.69
($30.64)
$ 47.3154%Sold Out0
ZTSJean-Marie Eveillard 2014-03-31 Reduce-0.26%$29.01 - $32.69
($30.64)
$ 47.3154%Reduce -43.39%3,763,386
ZTSLee Ainslie 2013-12-31 Add3.05%$31.04 - $33.22
($31.88)
$ 47.3148%Add 2021.15%7,635,025
ZTSGeorge Soros 2013-12-31 Add0.24%$31.04 - $33.22
($31.88)
$ 47.3148%Add 54.13%2,495,329
ZTSJean-Marie Eveillard 2013-09-30 Add0.5%$29.15 - $32.72
($30.63)
$ 47.3154%Add 1447.21%5,842,948
ZTSLee Ainslie 2013-09-30 Buy 0.15%$29.15 - $32.72
($30.63)
$ 47.3154%New holding, 359948 sh.359,948
ZTSMario Gabelli 2013-09-30 Add0.04%$29.15 - $32.72
($30.63)
$ 47.3154%Add 350.26%244,760
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZTS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ZTS Bill Ackman 2014-12-3141,569,6468.2911.1+650.78%
ZTS Mario Gabelli 2014-12-31626,8930.130.14+187.59%
ZTS George Soros 2014-12-314,106,7350.821.9+1.86%
ZTS Ruane Cunniff 2014-12-31173,4230.030.04+0.06%
ZTS Vanguard Health Care Fund 2014-12-319,178,6571.830.93-15%
ZTS Robert Olstein 2014-12-31141,0000.030.74-20.79%
ZTS John Keeley 2014-12-3162,1640.010.05-21.81%
ZTS Jean-Marie Eveillard 2014-12-31820,4670.160.09-62.26%
Premium Most recent portfolio changes are included for Premium Members only!


ZTS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MCCALLISTER MICHAEL BDirector 2013-08-08Buy7,000$31.3547.02view
Knupp Catherine A.Executive Vice President 2013-02-06Buy1,000$2677.27view
Chen Heidi C.Executive Vice President 2013-02-06Buy2,500$2677.27view
Beaty Sandra J.Executive Vice President 2013-02-06Buy2,000$2677.27view
STEERE WILLIAM C JRDirector 2013-02-06Buy4,500$2677.27view
Norden GregoryDirector 2013-02-06Buy3,000$2677.27view
SCHULMAN AMY WDirector 2013-02-06Buy5,000$2677.27view
HILL CHARLES HDirector 2013-02-06Buy5,000$2677.27view
Giordano Douglas E.Director 2013-02-06Buy5,000$2677.27view
Germano Geno JDirector 2013-02-06Buy5,000$2677.27view

Press Releases about ZTS :

    Quarterly/Annual Reports about ZTS:

    News about ZTS:

    Articles On GuruFocus.com
    Bill Ackman is keeping on buying Zoetis Feb 24 2015 
    Activist Investor Bill Ackman's Newest Additions to His Portfolio Feb 18 2015 
    Feeling Good With This Med Company Jan 20 2015 
    2015 - First Half Jan 01 2015 
    Zoetis in a Growing Global Animal Health Industry Dec 03 2014 
    Ackman’s Pershing Group Buys Stake in Zoetis Nov 13 2014 
    Activist Bill Ackman Buys Big Stake In Animal Healthcare Company Zoetis Nov 12 2014 
    Zoetis Will Benefit from Industry Trends Oct 07 2014 
    Guru Stocks at 52-Week Lows: HMC, NMR, SDRL, ZTS, BBBY Apr 21 2014 
    Morning Coffee: Widely Held Guru Stocks Near 52-Week Lows Apr 10 2014 

    More From Other Websites
    Zoetis Declares Second Quarter 2015 Dividend Feb 27 2015
    ZOETIS INC. Files SEC form 8-K, Regulation FD Disclosure Feb 27 2015
    Zoetis Declares Second Quarter 2015 Dividend Feb 27 2015
    Oculus Innovative Sciences No One Trick Pony With Launch of New Animal Healthcare Division Feb 27 2015
    A Top Pick From a Billionaire Just Broke Out Technically Feb 25 2015
    Trade Ideas Feb 25 2015
    Billionaire Bill Ackman’s Top Picks: Allergan Inc. (AGN), Air Products & Chemicals Inc. (APD),... Feb 19 2015
    ValueWalk On What Might Be Pershing Square's 'Big Secret Short' Feb 19 2015
    13F Watch: In Defense of Active Share Feb 19 2015
    Zoetis to Participate in the Barclays Global Healthcare Conference Feb 18 2015
    Zoetis to Participate in the Barclays Global Healthcare Conference Feb 18 2015
    Ackman's Pershing Square Scaled Back Allergan, Added To Platform Specialty Products In Q4 Feb 17 2015
    Making Money With Charles Payne: 02/13/15 Feb 13 2015
    Bill Ackman Thinks Valeant Is 'Incredibly Disciplined,' And Says He'd Own McDonald's If 3G Capital... Feb 13 2015
    Zoetis Flexes Muscles; Has "Pipeline Power," Says Barclays Feb 12 2015
    Must-See Charts: 5 Big Stocks With Breakout Potential Feb 12 2015
    Company News for February 12, 2015 - Corporate Summary Feb 12 2015
    Zoetis Inc. (ZTS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Feb 12 2015
    Zoetis Reports Fourth Quarter and Full Year 2014 Results Feb 12 2015
    Zoetis Profit Up 20%, 2015 Outlook Cut Slightly Feb 11 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK